Market Cap
JP¥4.6t
Last Updated
2020/10/19 14:56 UTC
Data Sources
Company Financials +
Executive Summary
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. More Details
Rewards
Risk Analysis
No risks detected for 7741 from our risk checks.
Snowflake Analysis
Flawless balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has HOYA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 7741 has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
1.6%
7741
-1.7%
JP Medical Equipment
-0.9%
JP Market
1 Year Return
33.3%
7741
28.0%
JP Medical Equipment
0.9%
JP Market
Return vs Industry: 7741 exceeded the JP Medical Equipment industry which returned 27.5% over the past year.
Return vs Market: 7741 exceeded the JP Market which returned 0.8% over the past year.
Shareholder returns
| 7741 | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.6% | -1.7% | -0.9% |
| 30 Day | 6.5% | 1.6% | -0.2% |
| 90 Day | 14.2% | 9.0% | 3.8% |
| 1 Year | 34.4%33.3% | 29.2%28.0% | 3.4%0.9% |
| 3 Year | 98.5%91.7% | 67.4%62.5% | 2.3%-4.9% |
| 5 Year | 183.0%165.1% | 118.4%107.7% | 22.4%8.9% |
Price Volatility Vs. Market
How volatile is HOYA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is HOYA undervalued compared to its fair value and its price relative to the market?
41.74x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 7741 (¥12235) is trading above our estimate of fair value (¥7512.12)
Significantly Below Fair Value: 7741 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 7741 is poor value based on its PE Ratio (41.7x) compared to the JP Medical Equipment industry average (25.7x).
PE vs Market: 7741 is poor value based on its PE Ratio (41.7x) compared to the JP market (16.7x).
Price to Earnings Growth Ratio
PEG Ratio: 7741 is poor value based on its PEG Ratio (3.6x)
Price to Book Ratio
PB vs Industry: 7741 is overvalued based on its PB Ratio (7x) compared to the JP Medical Equipment industry average (2.2x).
Next Steps
Future Growth
How is HOYA forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
11.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7741's forecast earnings growth (11.5% per year) is above the savings rate (0.05%).
Earnings vs Market: 7741's earnings (11.5% per year) are forecast to grow slower than the JP market (17.4% per year).
High Growth Earnings: 7741's earnings are forecast to grow, but not significantly.
Revenue vs Market: 7741's revenue (6.9% per year) is forecast to grow faster than the JP market (5.2% per year).
High Growth Revenue: 7741's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7741's Return on Equity is forecast to be high in 3 years time (21.6%)
Next Steps
Past Performance
How has HOYA performed over the past 5 years?
6.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7741 has high quality earnings.
Growing Profit Margin: 7741's current net profit margins (20.2%) are lower than last year (21.8%).
Past Earnings Growth Analysis
Earnings Trend: 7741's earnings have grown by 6.7% per year over the past 5 years.
Accelerating Growth: 7741's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 7741 had negative earnings growth (-10.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-7.8%).
Return on Equity
High ROE: 7741's Return on Equity (17.3%) is considered low.
Next Steps
Financial Health
How is HOYA's financial position?
Financial Position Analysis
Short Term Liabilities: 7741's short term assets (¥499.3B) exceed its short term liabilities (¥100.9B).
Long Term Liabilities: 7741's short term assets (¥499.3B) exceed its long term liabilities (¥49.5B).
Debt to Equity History and Analysis
Debt Level: 7741's debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: 7741's debt to equity ratio has reduced from 6.4% to 0.2% over the past 5 years.
Debt Coverage: 7741's debt is well covered by operating cash flow (10523.9%).
Interest Coverage: 7741 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is HOYA current dividend yield, its reliability and sustainability?
0.73%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 7741's dividend (0.74%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.33%).
High Dividend: 7741's dividend (0.74%) is low compared to the top 25% of dividend payers in the JP market (3.22%).
Stability and Growth of Payments
Stable Dividend: 7741's dividends per share have been stable in the past 10 years.
Growing Dividend: 7741's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (30.7%), 7741's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.3yrs
Average board tenure
CEO
Hiroshi Suzuki (62 yo)
17.33yrs
Tenure
JP¥168,000,000
Compensation
Mr. Hiroshi Suzuki has been the Chief Executive Officer of HOYA Corporation since June 2003 and has been its President since June 2000. Mr. Suzuki serves as Representative Executive Officer at HOYA Corpora ...
CEO Compensation Analysis
Compensation vs Market: Hiroshi's total compensation ($USD1.59M) is about average for companies of similar size in the JP market ($USD1.98M).
Compensation vs Earnings: Hiroshi's compensation has been consistent with company performance over the past year.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairperson of the Board | 17.33yrs | JP¥168.00m | 0.25% ¥ 11.6b | |
| Independent Director | 6.33yrs | no data | 0.00075% ¥ 34.7m | |
| Independent Director | 5.33yrs | no data | 0.00027% ¥ 12.5m | |
| Lead Independent Director | 1.75yrs | no data | 0.0013% ¥ 61.5m | |
| Independent Director | 7.33yrs | no data | 0.00027% ¥ 12.5m | |
| Independent Director | 2.33yrs | no data | no data |
5.3yrs
Average Tenure
72yo
Average Age
Experienced Board: 7741's board of directors are considered experienced (5.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
HOYA Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: HOYA Corporation
- Ticker: 7741
- Exchange: TSE
- Founded: 1941
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: JP¥4.625t
- Shares outstanding: 374.76m
- Website: https://www.hoya.co.jp
Number of Employees
Location
- HOYA Corporation
- Nittochi Nishishinjuku Building
- 20th Floor
- Tokyo
- 160-8347
- Japan
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HOCP.F | OTCPK (Pink Sheets LLC) | Yes | Common Stock | US | USD | Jan 1992 |
| HYB | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1992 |
| 7741 | TSE (The Tokyo Stock Exchange) | Yes | Common Stock | JP | JPY | Jan 1992 |
| HOCP.Y | OTCPK (Pink Sheets LLC) | SPONSORED ADR | US | USD | Sep 2004 |
Biography
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The L ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/10/19 14:56 |
| End of Day Share Price | 2020/10/16 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2020/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.